Tikun Olam Cannbit (TKUNF) Stock Price, Quote, News & History

Tikun Olam Cannbit Pharmaceuticals Ltd (TKUNF) Stock Price, Quote, News & History

TKUNFOTCGM

Trade with Public

$6.00

At close: Apr 10, 5:00 PM EST

Key Statistics

Open

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

6.00 - 6.00

Market Cap

$50.98K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Tikun Olam Cannbit Pharmaceuticals Ltd News

Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments

The first patient has been enrolled in SciSparc Ltd.'s clinical trial evaluating the effectiveness and safety of their CBD-based drug for treating children with autism spectrum disorder, marking a significant advancement in ASD treatment. CEO Oz Adler expressed excitement about this milestone, highlighting the potential impact of the SCI-210 therapy in managing ASD symptoms. The company plans to enroll 60 participants aged 5 to 18 for a 20-week trial, comparing SCI-210 therapy with standard CBD treatment, in collaboration with the National Autism Research Center. Partnering with Tikun Olam Cannbit Pharmaceuticals Ltd., SciSparc aims to bring SCI-210 to market in Israel initially, with global distribution pending regulatory approvals. Additionally, the company achieved patent approvals in Canada for their opioid and n-acylethanolamine combination for pain management, as well as validation for their core technology patent in 15 European countries, demonstrating their commitment to advancing cannabinoid-based therapeutics.

Jelena Martinovic

Medical Marijuana Now Available In Pharmacies Across Greece: First Patient With Arthritis Feels 'Relief'

Nina Zdinjak

Cannabis Market Evolves In Israel Amid War With Hamas, New Merger On The Horizon

Over the years, Israel has grown into an international giant in the cannabis industry.

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-988.00K

Investing Cash Flow (TTM)

519.00K

Financing Cash Flow (TTM)

-3.40M

Free Cash Flow (TTM)

-917.00K

Capital Expenditure (TTM)

Net Change in Cash (TTM)

-3.87M

Valuation Metrics

Enterprise Value

$10.58M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

PB Ratio (TTM)

Earnings Yield % (TTM)

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

Book Value / Share

Company Debt

Total Debt

$11.53M

LT Debt

$1.46M

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

-$1.23M

Total Cash

$308.00K

Debt to Equity

Issuance of Debt (TTM)

-$1.23M

Repayment of Debt (TTM)

-$1.23M

Key Statistics

Open

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

6.00 - 6.00

Market Cap

$50.98K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

About

Sector

Health Care

Industry

Pharmaceuticals

Tikun Olam Cannbit Pharmaceuticals Ltd is engaged in the business of growing and marketing medical cannabis.

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Tikun Olam Cannbit (TKUNF) stock?

You can purchase shares of Tikun Olam Cannbit (OTCGM:TKUNF) through any online brokerage.

View our list of the best stock brokerages

Who are Tikun Olam Cannbit (TKUNF) competitors?

There are no as such competitors for Tikun Olam Cannbit.

What is the forecast, or price target, for Tikun Olam Cannbit (TKUNF) stock?

There is no analysis for Tikun Olam Cannbit to provide a consensus price target.

What is the current price for Tikun Olam Cannbit (TKUNF)?

The stock price for Tikun Olam Cannbit (OTCGM: TKUNF) is $0.06 last updated September 17, 2025 at 9:35 AM EDT.

Does Tikun Olam Cannbit (TKUNF) pay a dividend?

There are no upcoming dividends for Tikun Olam Cannbit.

When is Tikun Olam Cannbit (OTCGM:TKUNF) reporting earnings?

Tikun Olam Cannbit does not have any upcoming earnings scheduled.

Is Tikun Olam Cannbit (TKUNF) going to split?

There is no upcoming split for Tikun Olam Cannbit.

What sector and industry does Tikun Olam Cannbit (TKUNF) operate in?

Tikun Olam Cannbit is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCGM.

Key Statistics

Open

Volume / Avg.

0 / -

Day Range

- - -

52 Wk Range

6.00 - 6.00

Market Cap

$50.98K

P/E Ratio

Dividend Yield

Exchange

OTC

RSI

Short Interest

Days to Cover

Recent Tikun Olam Cannbit Pharmaceuticals Ltd News

Autism CBD Trial Enrolls Children: This Israeli Co. Is Making Headway In New Treatments

Jelena Martinovic

Medical Marijuana Now Available In Pharmacies Across Greece: First Patient With Arthritis Feels 'Relief'

Nina Zdinjak

Cannabis Market Evolves In Israel Amid War With Hamas, New Merger On The Horizon

Over the years, Israel has grown into an international giant in the cannabis industry.

Jelena Martinovic